Hammersbach, Germany

Rolf Hoffmann



Average Co-Inventor Count = 2.4

ph-index = 1


Company Filing History:


Years Active: 2010-2013

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Rolf Hoffmann: Innovator in Amino Acid Derivatives

Introduction

Rolf Hoffmann is a notable inventor based in Hammersbach, Germany. He has made significant contributions to the field of chemistry, particularly in the preparation of bioactive agents and amino acids. With a total of 2 patents, Hoffmann's work has implications for various applications in pharmaceuticals and biochemistry.

Latest Patents

Hoffmann's latest patents include a process for preparing n-protected 4-ketoproline derivatives. This invention focuses on a method for synthesizing compounds that can be utilized to create bioactive agents. The process begins with the corresponding hydroxy compounds, which are oxidized using ruthenium catalysis in a one-phase aqueous system. Another significant patent involves the preparation of enantiomerically enriched amino acids. This invention addresses the resolution of a mixture of enantiomers of N-protected amino acids through crystallization with enantiomerically pure N-unprotected β-amino acid derivatives.

Career Highlights

Throughout his career, Rolf Hoffmann has worked with prominent companies such as Degussa Aktiengesellschaft and Evonik Degussa GmbH. His experience in these organizations has allowed him to develop and refine his innovative processes in the field of chemistry.

Collaborations

Hoffmann has collaborated with notable colleagues, including Michael Kraft and Kai Rossen. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Rolf Hoffmann's contributions to the field of chemistry, particularly in the area of amino acid derivatives, highlight his innovative spirit and dedication to advancing scientific knowledge. His patents reflect a commitment to developing processes that can lead to the creation of valuable bioactive agents.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…